Similar articles

• [Effectiveness of the treatment of severe cases of fetal erythroblastosis by intrauterine blood transfusion].

  Lukaszewicz E, Korzycki J, Debski R, Ciastoń W, Falecka K, Latoszewska W, Marianowski L. Lukaszewicz E, et al. Acta Haematol Pol. 1988 Jul-Dec;19(3-4):212-6. Acta Haematol Pol. 1988. PMID: 3150897 Polish. No abstract available.
• Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).

  Felc Z. Felc Z. East Mediterr Health J. 2001 Nov;7(6):1065-9. East Mediterr Health J. 2001. PMID: 15332750 No abstract available.
• [Critical comments on the current treatment of neonatal hemolytic diseases due to anti-Rh(D) isoimmunization].

  Velcovici D, Grigoriu G. Velcovici D, et al. Rev Pediatr Obstet Ginecol Pediatr. 1986 Oct-Dec;35(4):345-59. Rev Pediatr Obstet Ginecol Pediatr. 1986. PMID: 3105027 Review. Romanian. No abstract available.
• [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].

  Lozińska D, Radomska I, Samborska K, Dmoch E, Garwoliński J, Lenkiewicz B, Góralski T. Lozińska D, et al. Pol Tyg Lek. 1988 Nov 7;43(45):1449-51. Pol Tyg Lek. 1988. PMID: 3151013 Polish. No abstract available.
• Rescue in inner space: management of Rh hemolytic disease.

  Liley HG. Liley HG. J Pediatr. 1997 Sep;131(3):340-2. doi: 10.1016/s0022-3476(97)80053-4. J Pediatr. 1997. PMID: 9329405 Review. No abstract available.